Uridine 5-Prime Monophosphate Hydrolase Deficiency, Hemolytic Anemia due to
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
10
|
0.700 |
None |
1.000 |
10 |
10
|
2001 |
2016 |
Anemia, Hemolytic, Congenital Nonspherocytic
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
5
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Chloracne
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
38
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Anemia, Hemolytic
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
154
|
31
|
0.130 |
None |
1.000 |
3 |
|
2004 |
2008 |
RDW - Red blood cell distribution width result
|
phenotype |
|
Laboratory or Test Result
|
593
|
988
|
0.100 |
None |
1.000 |
3 |
2
|
2016 |
2019 |
Red cell distribution width determination
|
phenotype |
|
Laboratory Procedure
|
593
|
988
|
0.100 |
None |
1.000 |
3 |
2
|
2016 |
2019 |
Glomerular Filtration Rate
|
phenotype |
|
Diagnostic Procedure
|
399
|
1033
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Hemoglobinuria
|
disease |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Finding
|
8
|
|
0.100 |
None |
|
0 |
|
|
|
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.050 |
None |
1.000 |
5 |
|
1995 |
2002 |
Malignant neoplasm of pancreas
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
2667
|
277
|
0.040 |
None |
1.000 |
4 |
|
2002 |
2017 |
Pancreatic carcinoma
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
2689
|
322
|
0.040 |
None |
1.000 |
4 |
|
2002 |
2017 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.030 |
None |
1.000 |
3 |
|
2001 |
2018 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.030 |
None |
1.000 |
3 |
1
|
2002 |
2014 |
Malaria
|
disease |
Infections
|
Disease or Syndrome
|
685
|
148
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2017 |
Central neuroblastoma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
2419
|
231
|
0.020 |
None |
1.000 |
2 |
|
1995 |
1999 |
Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2509
|
386
|
0.020 |
None |
1.000 |
2 |
|
1995 |
1999 |
Brain Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
1018
|
204
|
0.020 |
None |
1.000 |
2 |
|
2001 |
2001 |
Crohn Disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1382
|
1147
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2000 |
Childhood Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2420
|
231
|
0.020 |
None |
1.000 |
2 |
|
1995 |
1999 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.020 |
None |
1.000 |
2 |
|
1990 |
1995 |
Diabetes Mellitus, Non-Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
3134
|
2672
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Paratuberculosis
|
disease |
Infections; Animal Diseases
|
Disease or Syndrome
|
61
|
6
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2000 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
2001 |
2018 |
Motor symptoms
|
phenotype |
|
Sign or Symptom
|
100
|
15
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Lupus Erythematosus
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
558
|
44
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |